| Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer (NCT01564810) | Xu jianmin | 2006-09-01 |
| Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver Metastasis (NCT00392366) | BioTex, Inc. | 2006-07-01 |
| A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) (NCT00355355) | Light Sciences Oncology | 2006-07-01 |
| An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer (NCT00247676) | Pfizer | 2006-02-01 |
| Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases (NCT00106054) | Pfizer | 2006-01-01 |
| Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) (NCT00122876) | Light Sciences Oncology | 2005-04-01 |
| Inferior Vena Cava Index in Patients Undergoing Liver Resection (NCT02404909) | University of Milan | 2005-01-01 |
| The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver Metastases (NCT00145665) | Radboud University Medical Center | 2005-01-01 |
| Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver (NCT00149396) | MediGene | 2004-07-01 |
| Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases (NCT00083785) | Light Sciences LLC | 2004-05-01 |
| Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors (NCT00081848) | National Cancer Institute (NCI) | 2004-04-20 |
| Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases (NCT00068068) | Light Sciences LLC | 2003-10-01 |
| Stereotactic Radiotherapy (SRT) Liver (COLD 1) (NCT00152906) | University Health Network, Toronto | 2003-07-01 |
| Study of NS-9 in Patients With Liver Metastases (NCT00094003) | NS Pharma, Inc. | 2002-09-01 |
| HAI Via Interventionally Implanted Port Catheter Systems (NCT00356161) | Charite University, Berlin, Germany | 2002-04-01 |
| Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer (NCT00143403) | Pfizer | 2001-12-01 |
| Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver (NCT00041808) | FeRx | 2001-07-01 |
| Orthotopic Liver Transplantation Using a Living Donor (NCT00152607) | University of Chicago | 2000-04-01 |
| Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma (NCT00051545) | LEO Pharma | 1999-11-01 |
| Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma (NCT00051532) | LEO Pharma | 1999-09-01 |
| Genetic Susceptibility to Oncogenic Viruses (NCT00341484) | National Cancer Institute (NCI) | 1998-06-01 |
| A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver (NCT00001587) | National Cancer Institute (NCI) | 1997-09-01 |
| Qidong Hepatitis B Intervention Study (NCT00222664) | University of Oxford | 1983-09-01 |
| Therasphere for Unresectable Primary or Secondary Liver Neoplasia (NCT02960620) | H. Lee Moffitt Cancer Center and Research Institute | |
| Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation (NCT00178243) | University of Rochester | |